Author:
Strupp C,Germing U,Aivado M,Misgeld E,Haas R,Gattermann N
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference22 articles.
1. Willman CL, Barrett AJ, Saunthararajah Y, Hellström-Lindberg E . Achievements in understanding and treatment of myelodysplastic syndromes Hematology American Society of Hematology: Washington 2000 pp 110–132
2. Zwingenberger K, Wnendt S . Immunmodulation by thalidomide: systematic review of the literature and of unpublished results J Inflamm 1995–1996 46: 177–211
3. Verbon A, Juffermans NP, Speelman P, van Deventer SJH, Ten Berge IJM, Guchelaar HJ, van der Poll T . A single oral dose of thalidomide enhances the capacity of lymphocytes to secrete gamma interferon in healthy humans Antimicrobial agentschemother 2000 44: 2286–2290
4. Haslett PAJ, Corrall LG, Albert M, Kaplan G . Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset J Exp Med 1998 187: 1885–1892
5. McHugh SM, Rifkin IR, Deighton J, Wilson AB, Lachmann PJ, Lockwood CM, Ewan PW . The immunosuppressive drug thalidomide induces T helper cell type 2 (Th 2) and concomitantly inhibits Th 1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures Clin Exp Immunol 1995 99: 160–167
Cited by
126 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献